Generali Investments Management Co LLC Invests $1.37 Million in Colgate-Palmolive (NYSE:CL)

Generali Investments Management Co LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CLFree Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 15,095 shares of the company’s stock, valued at approximately $1,372,000.

Several other hedge funds and other institutional investors have also modified their holdings of the company. West Tower Group LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter worth $482,000. Enhancing Capital LLC purchased a new position in Colgate-Palmolive in the fourth quarter valued at $364,000. Intech Investment Management LLC boosted its holdings in Colgate-Palmolive by 312.0% in the fourth quarter. Intech Investment Management LLC now owns 545,551 shares of the company’s stock valued at $49,596,000 after purchasing an additional 413,134 shares during the period. Generali Asset Management SPA SGR purchased a new position in Colgate-Palmolive in the fourth quarter valued at $8,105,000. Finally, Mirova US LLC boosted its holdings in Colgate-Palmolive by 16.3% in the fourth quarter. Mirova US LLC now owns 11,849 shares of the company’s stock valued at $1,077,000 after purchasing an additional 1,659 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. UBS Group decreased their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. JPMorgan Chase & Co. lifted their target price on Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a report on Friday, March 14th. Raymond James reaffirmed an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Piper Sandler decreased their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $101.72.

Read Our Latest Research Report on CL

Colgate-Palmolive Stock Down 1.4 %

CL opened at $89.45 on Wednesday. The business’s 50-day simple moving average is $89.13 and its 200-day simple moving average is $94.44. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The stock has a market capitalization of $72.59 billion, a P/E ratio of 25.41, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the firm posted $0.87 EPS. Analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.